The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Insulin Pens-Global Market Insights and Sales Trends 2024
Synopsis
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.
The global Insulin Pens market size is expected to reach US$ 7316.7 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Pens in various end use industries. The expanding demands from the Home Use, Medical Institutions and Others,, are propelling Insulin Pens market. Standard Insulin Pen Needles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Safety Insulin Pen Needles segment is estimated at % CAGR for the next seven-year period.
EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.
The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Pens, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Pens market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Pens market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Pens sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Pens covered in this report include BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa and Beipu, etc.
The global Insulin Pens market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Dongbao
Global Insulin Pens market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Pens market, Segment by Type:
Standard Insulin Pen Needles
Safety Insulin Pen Needles
Global Insulin Pens market, by Application
Home Use
Medical Institutions
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Pens manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Pens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.
The global Insulin Pens market size is expected to reach US$ 7316.7 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Pens in various end use industries. The expanding demands from the Home Use, Medical Institutions and Others,, are propelling Insulin Pens market. Standard Insulin Pen Needles, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Safety Insulin Pen Needles segment is estimated at % CAGR for the next seven-year period.
EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.
The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Pens, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Pens market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Pens market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Pens sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Pens covered in this report include BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa and Beipu, etc.
The global Insulin Pens market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Dongbao
Global Insulin Pens market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Pens market, Segment by Type:
Standard Insulin Pen Needles
Safety Insulin Pen Needles
Global Insulin Pens market, by Application
Home Use
Medical Institutions
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Pens manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Pens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Insulin Pens Market Overview
1.1 Insulin Pens Product Overview
1.2 Insulin Pens Market Segment by Type
1.2.1 Standard Insulin Pen Needles
1.2.2 Safety Insulin Pen Needles
1.3 Global Insulin Pens Market Size by Type
1.3.1 Global Insulin Pens Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Pens Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Pens Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Pens Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Pens Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Pens Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Pens Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Pens Sales Breakdown by Type (2018-2023)
2 Global Insulin Pens Market Competition by Company
2.1 Global Top Players by Insulin Pens Sales (2018-2023)
2.2 Global Top Players by Insulin Pens Revenue (2018-2023)
2.3 Global Top Players by Insulin Pens Price (2018-2023)
2.4 Global Top Manufacturers Insulin Pens Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Pens Market Competitive Situation and Trends
2.5.1 Insulin Pens Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Pens Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Pens as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Pens Market
2.8 Key Manufacturers Insulin Pens Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Pens Status and Outlook by Region
3.1 Global Insulin Pens Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Pens Historic Market Size by Region
3.2.1 Global Insulin Pens Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Pens Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Pens Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Pens Forecasted Market Size by Region
3.3.1 Global Insulin Pens Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Pens Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Pens Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin Pens by Application
4.1 Insulin Pens Market Segment by Application
4.1.1 Home Use
4.1.2 Medical Institutions
4.1.3 Others
4.2 Global Insulin Pens Market Size by Application
4.2.1 Global Insulin Pens Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Pens Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Pens Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Pens Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Pens Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Pens Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Pens Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Pens Sales Breakdown by Application (2018-2023)
5 North America Insulin Pens by Country
5.1 North America Insulin Pens Historic Market Size by Country
5.1.1 North America Insulin Pens Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Pens Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Pens Sales in Value by Country (2018-2023)
5.2 North America Insulin Pens Forecasted Market Size by Country
5.2.1 North America Insulin Pens Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Pens Sales in Value by Country (2024-2029)
6 Europe Insulin Pens by Country
6.1 Europe Insulin Pens Historic Market Size by Country
6.1.1 Europe Insulin Pens Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Pens Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Pens Sales in Value by Country (2018-2023)
6.2 Europe Insulin Pens Forecasted Market Size by Country
6.2.1 Europe Insulin Pens Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Pens Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin Pens by Region
7.1 Asia-Pacific Insulin Pens Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Pens Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Pens Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Pens Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Pens Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Pens Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Pens Sales in Value by Region (2024-2029)
8 Latin America Insulin Pens by Country
8.1 Latin America Insulin Pens Historic Market Size by Country
8.1.1 Latin America Insulin Pens Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Pens Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Pens Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Pens Forecasted Market Size by Country
8.2.1 Latin America Insulin Pens Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Pens Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin Pens by Country
9.1 Middle East and Africa Insulin Pens Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Pens Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Pens Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Pens Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Pens Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Pens Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Pens Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BD
10.1.1 BD Company Information
10.1.2 BD Introduction and Business Overview
10.1.3 BD Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BD Insulin Pens Products Offered
10.1.5 BD Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novo Nordisk Insulin Pens Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Artsana
10.3.1 Artsana Company Information
10.3.2 Artsana Introduction and Business Overview
10.3.3 Artsana Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Artsana Insulin Pens Products Offered
10.3.5 Artsana Recent Development
10.4 B. Braun
10.4.1 B. Braun Company Information
10.4.2 B. Braun Introduction and Business Overview
10.4.3 B. Braun Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.4.4 B. Braun Insulin Pens Products Offered
10.4.5 B. Braun Recent Development
10.5 Terumo
10.5.1 Terumo Company Information
10.5.2 Terumo Introduction and Business Overview
10.5.3 Terumo Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Terumo Insulin Pens Products Offered
10.5.5 Terumo Recent Development
10.6 Ypsomed
10.6.1 Ypsomed Company Information
10.6.2 Ypsomed Introduction and Business Overview
10.6.3 Ypsomed Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ypsomed Insulin Pens Products Offered
10.6.5 Ypsomed Recent Development
10.7 Owen Mumford
10.7.1 Owen Mumford Company Information
10.7.2 Owen Mumford Introduction and Business Overview
10.7.3 Owen Mumford Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Owen Mumford Insulin Pens Products Offered
10.7.5 Owen Mumford Recent Development
10.8 HTL-Strefa
10.8.1 HTL-Strefa Company Information
10.8.2 HTL-Strefa Introduction and Business Overview
10.8.3 HTL-Strefa Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.8.4 HTL-Strefa Insulin Pens Products Offered
10.8.5 HTL-Strefa Recent Development
10.9 Beipu
10.9.1 Beipu Company Information
10.9.2 Beipu Introduction and Business Overview
10.9.3 Beipu Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beipu Insulin Pens Products Offered
10.9.5 Beipu Recent Development
10.10 Kangdelai
10.10.1 Kangdelai Company Information
10.10.2 Kangdelai Introduction and Business Overview
10.10.3 Kangdelai Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Kangdelai Insulin Pens Products Offered
10.10.5 Kangdelai Recent Development
10.11 Ulticare
10.11.1 Ulticare Company Information
10.11.2 Ulticare Introduction and Business Overview
10.11.3 Ulticare Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ulticare Insulin Pens Products Offered
10.11.5 Ulticare Recent Development
10.12 Allison Medical
10.12.1 Allison Medical Company Information
10.12.2 Allison Medical Introduction and Business Overview
10.12.3 Allison Medical Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Allison Medical Insulin Pens Products Offered
10.12.5 Allison Medical Recent Development
10.13 Dongbao
10.13.1 Dongbao Company Information
10.13.2 Dongbao Introduction and Business Overview
10.13.3 Dongbao Insulin Pens Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Dongbao Insulin Pens Products Offered
10.13.5 Dongbao Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Pens Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Pens Industrial Chain Analysis
11.4 Insulin Pens Market Dynamics
11.4.1 Insulin Pens Industry Trends
11.4.2 Insulin Pens Market Drivers
11.4.3 Insulin Pens Market Challenges
11.4.4 Insulin Pens Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Pens Distributors
12.3 Insulin Pens Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
